Arsenic metabolism, diabetes prevalence, and insulin resistance among Mexican Americans: A mendelian randomization approach

[1]  Molly Scannell Bryan,et al.  Relationships Between Urinary Metals and Diabetes Traits Among Mexican Americans in Starr County, Texas, USA , 2022, Biological Trace Element Research.

[2]  L. López-Carrillo,et al.  Prevalence of type 2 diabetes mellitus in relation to arsenic exposure and metabolism in Mexican women. , 2022, Environmental research.

[3]  Kun Lu,et al.  The gut microbiome and arsenic-induced disease—iAs metabolism in mice , 2021, Current Environmental Health Reports.

[4]  Fen Wu,et al.  Arsenic Exposure, Arsenic Metabolism, and Glycemia: Results from a Clinical Population in New York City , 2021, International journal of environmental research and public health.

[5]  R. Sargis,et al.  Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic. , 2021, Advances in pharmacology.

[6]  Shuang Liu,et al.  Arsenic induces hepatic insulin resistance via mtROS-NLRP3 inflammasome pathway. , 2020, Journal of hazardous materials.

[7]  F. Jasmine,et al.  Assessing the impact of arsenic metabolism efficiency on DNA methylation using Mendelian randomization , 2020, Environmental epidemiology.

[8]  Charles R. Evans,et al.  Metabolomic profiles associated with subtypes of prediabetes among Mexican Americans in Starr County, Texas, USA , 2019, Diabetologia.

[9]  Shuang Liu,et al.  Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway. , 2019, Journal of hazardous materials.

[10]  B. Coull,et al.  Gene-environment interaction and maternal arsenic methylation efficiency during pregnancy , 2019, Environment international.

[11]  D. Zeng,et al.  Mendelian randomization of inorganic arsenic metabolism as a risk factor for hypertension- and diabetes-related traits among adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort. , 2019, International journal of epidemiology.

[12]  B. Howard,et al.  Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study. , 2018, Environment international.

[13]  M. Stýblo,et al.  Impact of in vitro heavy metal exposure on pancreatic β-cell function. , 2018, Toxicology letters.

[14]  S. Seino,et al.  Arsenic exposure induces glucose intolerance and alters global energy metabolism. , 2018, American journal of physiology. Regulatory, integrative and comparative physiology.

[15]  Tyler D. Johnson,et al.  Domestic well locations and populations served in the contiguous U.S.: 1990. , 2017, Science of the Total Environment.

[16]  B. Howard,et al.  Association of Low-Moderate Arsenic Exposure and Arsenic Metabolism with Incident Diabetes and Insulin Resistance in the Strong Heart Family Study , 2017, Environmental health perspectives.

[17]  E. Silbergeld,et al.  The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence , 2017, Environmental health perspectives.

[18]  J. Kaufman,et al.  Estimation of Inorganic Arsenic Exposure in Populations With Frequent Seafood Intake: Evidence From MESA and NHANES. , 2016, American journal of epidemiology.

[19]  Sayan Chakraborty,et al.  Association of single nucleotide polymorphism with arsenic-induced skin lesions and genetic damage in exposed population of West Bengal, India. , 2016, Mutation research.

[20]  S. Redline,et al.  Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas , 2016, Cardiovascular Diabetology.

[21]  B. Jackson.  Fast ion chromatography-ICP-QQQ for arsenic speciation. , 2015, Journal of analytical atomic spectrometry.

[22]  How-Ran Guo,et al.  Association between Arsenic Exposure and Diabetes: A Meta-Analysis , 2015, BioMed research international.

[23]  R. Jain.  Association of arsenic exposure with smoking, alcohol, and caffeine consumption: data from NHANES 2005-2010. , 2015, Environmental toxicology and pharmacology.

[24]  B. Howard,et al.  Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study , 2014, Diabetes Care.

[25]  Xu-xiang Zhang,et al.  Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice , 2014, Scientific Reports.

[26]  M. Mendez,et al.  Associations between Arsenic Species in Exfoliated Urothelial Cells and Prevalence of Diabetes among Residents of Chihuahua, Mexico , 2014, Environmental health perspectives.

[27]  R. Sargis.  The Hijacking of Cellular Signaling and the Diabetes Epidemic: Mechanisms of Environmental Disruption of Insulin Action and Glucose Homeostasis , 2014, Diabetes & metabolism journal.

[28]  C. Crainiceanu,et al.  Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study , 2013, Environmental Health.

[29]  J. Baron,et al.  Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction. , 2013, International journal of epidemiology.

[30]  Fei Wang,et al.  Arsenic induces the expressions of angiogenesis-related factors through PI3K and MAPK pathways in SV-HUC-1 human uroepithelial cells. , 2013, Toxicology letters.

[31]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[32]  D. Loomis,et al.  Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico , 2013, Journal of Exposure Science and Environmental Epidemiology.

[33]  H. Yatsuya,et al.  Differences in Urinary Arsenic Metabolites between Diabetic and Non-Diabetic Subjects in Bangladesh , 2013, International journal of environmental research and public health.

[34]  Tomáš Matoušek,et al.  Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. , 2013, Toxicology and applied pharmacology.

[35]  C. Crainiceanu,et al.  Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. , 2012, American journal of epidemiology.

[36]  B. Howard,et al.  Arsenic species and selected metals in human urine: validation of HPLC/ICPMS and ICPMS procedures for a long-term population-based epidemiological study. , 2012, Analytical methods : advancing methods and applications.

[37]  J. Baron,et al.  Genome-Wide Association Study Identifies Chromosome 10q24.32 Variants Associated with Arsenic Metabolism and Toxicity Phenotypes in Bangladesh , 2012, PLoS genetics.

[38]  D. Loomis,et al.  Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico , 2011, Environmental health : a global access science source.

[39]  M. Vahter,et al.  Impact of Smoking and Chewing Tobacco on Arsenic-Induced Skin Lesions , 2009, Environmental health perspectives.

[40]  C. Tseng.  A review on environmental factors regulating arsenic methylation in humans. , 2009, Toxicology and applied pharmacology.

[41]  Ellen K Silbergeld,et al.  Arsenic exposure and prevalence of type 2 diabetes in US adults. , 2008, JAMA.

[42]  L. Platanias,et al.  Exploiting the mammalian target of rapamycin pathway in hematologic malignancies , 2008, Current opinion in hematology.

[43]  L. D. Del Razo,et al.  Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. , 2007, Environmental research.

[44]  M. Vahter,et al.  Arsenic Exposure and Age- and Sex-Specific Risk for Skin Lesions: A Population-Based Case–Referent Study in Bangladesh , 2006, Environmental health perspectives.

[45]  E. Guallar,et al.  Arsenic Exposure and Type 2 Diabetes: A Systematic Review of the Experimental and Epidemiologic Evidence , 2005, Environmental health perspectives.

[46]  David S. Paul,et al.  Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. , 2004, Toxicology and applied pharmacology.

[47]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[48]  M. Bazuine,et al.  Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. , 2003, European journal of biochemistry.

[49]  K. Nair,et al.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Jianping Chen,et al.  Arsenite Activation of PI3K/AKT Cell Survival Pathway is Mediated by p38 in Cultured Human Keratinocytes , 2001 .

[51]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[52]  W C Willett,et al.  Adjustment for total energy intake in epidemiologic studies. , 1997, The American journal of clinical nutrition.

[53]  M. Gonsebatt,et al.  Altered profile of urinary arsenic metabolites in adults with chronic arsenicism A pilot study , 1997, Archives of Toxicology.

[54]  W J Schull,et al.  Diabetes among Mexican Americans in Starr County, Texas. , 1983, American journal of epidemiology.